[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BiotechCH Avatar @BiotechCH Biotech Hangout

Biotech Hangout posts on X about $rares the most. They currently have XXXXXX followers and XXX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #

Social category influence finance

Social topic influence $rares

Top Social Posts #

Top posts by engagements in the last XX hours

"Are there ways for the FDA and biotechs to work together and eliminate bureaucratic red tape that slows time to market @adamfeuerstein points to the recent CRL for $RAREs gene therapy for Sanfilippo syndrome which was rejected over the number of thermometer probes in shipping containers. I think this frustrates a lot of the industry. People have called for common sense ways to eliminate these types of roadblocks and hurdles to streamline drug controlsNow this is a gene therapy that instead of being approved in August may not be approved until 2026. For patients that's a significant meaningful"
@BiotechCH Avatar @BiotechCH on X 2025-07-18 16:40:51 UTC 14.6K followers, XXX engagements

"As CEO I felt that it was doing something. I didn't think it was a cure or the best technology that was ever produced but we thought it deserved to be approved. I think that transparency is the issue and I think that's what @adamfeuerstein hit on shares @cngarabedian on the scrutiny biotech leaders can face. That credibility is a really important part for buy siders to invest and trust the story that they're being told by a management team. #BiotechHangout"
@BiotechCH Avatar @BiotechCH on X 2025-07-18 16:39:58 UTC 14.6K followers, XXX engagements